Display Settings:

Format

Send to:

Choose Destination
    Ned Tijdschr Geneeskd. 2009;153:A330.

    [Oral blood glucose-lowering medication as a monotherapy in gestational diabetes: a hotly debated topic].

    [Article in Dutch]

    Source

    Universitair Medisch Centrum Utrecht, afd. Interne Geneeskunde, Utrecht, The Netherlands. h.w.devalk@umcutrecht.nl

    Abstract

    Treatment of gestational diabetes mellitus is a hotly debated topic. In a recent randomized trial, metformin as a monotherapy achieved maternal and neonatal outcomes comparable to insulin treatment. In 2000, a randomized trial reported a similar favourable result with glibenclamide. The logical conclusion would be that either drug could already have a place in the usual treatment strategy in gestational diabetes. However, a number of major methodological, design and interpretation issues and shortcomings have led to the conclusion that such a point of view is not currently tenable. Therefore, neither metformin nor glibenclamide can yet have an established place as monotherapies in gestational diabetes; they can be used only in exceptionally cases.

    PMID:
    19785815
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk